PL375868A1 - Tiotropium containing hfc solution formulations - Google Patents
Tiotropium containing hfc solution formulationsInfo
- Publication number
- PL375868A1 PL375868A1 PL03375868A PL37586803A PL375868A1 PL 375868 A1 PL375868 A1 PL 375868A1 PL 03375868 A PL03375868 A PL 03375868A PL 37586803 A PL37586803 A PL 37586803A PL 375868 A1 PL375868 A1 PL 375868A1
- Authority
- PL
- Poland
- Prior art keywords
- solution formulations
- containing hfc
- hfc solution
- tiotropium containing
- tiotropium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02028238 | 2002-12-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL375868A1 true PL375868A1 (en) | 2005-12-12 |
Family
ID=32524008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03375868A PL375868A1 (en) | 2002-12-16 | 2003-12-04 | Tiotropium containing hfc solution formulations |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1575588A1 (xx) |
| JP (1) | JP2006510680A (xx) |
| KR (1) | KR20050085650A (xx) |
| CN (1) | CN1726038A (xx) |
| AU (1) | AU2003303029A1 (xx) |
| BR (1) | BR0317340A (xx) |
| CA (1) | CA2510043A1 (xx) |
| IL (1) | IL169178A0 (xx) |
| MX (1) | MXPA05006383A (xx) |
| PL (1) | PL375868A1 (xx) |
| RU (1) | RU2005122444A (xx) |
| WO (1) | WO2004054580A1 (xx) |
| ZA (1) | ZA200503546B (xx) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7273603B2 (en) * | 2003-07-11 | 2007-09-25 | Boehringer Ingelheim International Gmbh | HFC solution formulations containing an anticholinergic |
| MX2007013691A (es) * | 2005-05-02 | 2008-01-21 | Boehringer Ingelheim Int | Nuevas formas cristalinas de bromuro de tiotropio. |
| RU2417224C2 (ru) * | 2005-05-02 | 2011-04-27 | Бёрингер Ингельхайм Интернациональ Гмбх | Новые кристаллические формы тиотропийбромида |
| BRPI0608427A2 (pt) | 2005-12-19 | 2009-12-29 | Sicor Inc | novas formas de brometo de tiotrópio e processos para seu preparo |
| US9108962B2 (en) | 2005-12-19 | 2015-08-18 | Sicor, Inc. | Forms of tiotropium bromide and processes for preparation thereof |
| EP2201934A1 (en) | 2008-12-23 | 2010-06-30 | CHIESI FARMACEUTICI S.p.A. | Tiotropium aerosol formulation products with improved chemical stability |
| NZ600790A (en) | 2009-12-23 | 2014-09-26 | Chiesi Farma Spa | Combination therapy for copd |
| PT2515854E (pt) | 2009-12-23 | 2014-05-27 | Chiesi Farma Spa | Formulação de aerossol para dpoc |
| GB201200525D0 (en) * | 2011-12-19 | 2012-02-29 | Teva Branded Pharmaceutical Prod R & D Inc | An inhalable medicament |
| GB201200504D0 (en) * | 2011-12-19 | 2012-02-22 | Teva Branded Pharmaceutical Prod R & D Inc | An inhaler |
| JP6335798B2 (ja) | 2012-02-28 | 2018-05-30 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規噴射剤含有チオトロピウム製剤 |
| BR112015006571A2 (pt) * | 2012-10-23 | 2017-07-04 | Cipla Ltd | composição farmacêutica, processo para preparar uma composição farmacêutica, uso de uma composição farmacêutica, e, método para a profilaxia ou tratamento de asma, doença pulmonar obstrutiva crônica e distúrbios respiratórios relacionados |
| DK2897588T3 (da) * | 2013-11-22 | 2019-08-12 | Teva Branded Pharmaceutical Products R&D Inc | Inhalerbart lægemiddel |
| US10034866B2 (en) | 2014-06-19 | 2018-07-31 | Teva Branded Pharmaceutical Products R&D, Inc. | Inhalable medicament comprising tiotropium |
| CA3036628C (en) * | 2016-09-19 | 2021-11-16 | Mexichem Fluor S.A. De C.V. | Pharmaceutical compositions comprising tiotropium bromide monohydrate and 1,1-difluoroethane |
| AU2017328908B2 (en) * | 2016-09-19 | 2020-04-02 | Mexichem Fluor S.A. De C.V. | Pharmaceutical composition |
| CN114515284A (zh) | 2016-09-19 | 2022-05-20 | 墨西哥氟石股份公司 | 药物组合物 |
| CN109715160A (zh) | 2016-09-19 | 2019-05-03 | 墨西哥氟石股份公司 | 药物组合物 |
| ES2877575T3 (es) | 2016-09-19 | 2021-11-17 | Mexichem Fluor Sa De Cv | Composición farmacéutica que comprende salmeterol |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RO117414B1 (ro) * | 1992-12-09 | 2002-03-29 | Jager Paul D Waterbury | Compozitie farmaceutica de aerosol in solutie |
| DE10056104A1 (de) * | 2000-11-13 | 2002-05-23 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols |
-
2003
- 2003-12-04 AU AU2003303029A patent/AU2003303029A1/en not_active Abandoned
- 2003-12-04 CA CA002510043A patent/CA2510043A1/en not_active Abandoned
- 2003-12-04 RU RU2005122444/15A patent/RU2005122444A/ru not_active Application Discontinuation
- 2003-12-04 MX MXPA05006383A patent/MXPA05006383A/es not_active Application Discontinuation
- 2003-12-04 KR KR1020057010885A patent/KR20050085650A/ko not_active Application Discontinuation
- 2003-12-04 EP EP03813106A patent/EP1575588A1/en not_active Withdrawn
- 2003-12-04 WO PCT/EP2003/013692 patent/WO2004054580A1/en active Application Filing
- 2003-12-04 PL PL03375868A patent/PL375868A1/xx unknown
- 2003-12-04 CN CNA2003801063667A patent/CN1726038A/zh active Pending
- 2003-12-04 JP JP2004559752A patent/JP2006510680A/ja active Pending
- 2003-12-04 BR BR0317340-2A patent/BR0317340A/pt not_active Expired - Fee Related
-
2005
- 2005-05-04 ZA ZA200503546A patent/ZA200503546B/xx unknown
- 2005-06-15 IL IL169178A patent/IL169178A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200503546B (en) | 2006-10-25 |
| WO2004054580A1 (en) | 2004-07-01 |
| AU2003303029A1 (en) | 2004-07-09 |
| JP2006510680A (ja) | 2006-03-30 |
| CN1726038A (zh) | 2006-01-25 |
| IL169178A0 (en) | 2007-07-04 |
| RU2005122444A (ru) | 2007-01-27 |
| MXPA05006383A (es) | 2005-08-29 |
| KR20050085650A (ko) | 2005-08-29 |
| CA2510043A1 (en) | 2004-07-01 |
| BR0317340A (pt) | 2005-11-08 |
| EP1575588A1 (en) | 2005-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL169178A0 (en) | Tiotropium containing hfc solution formulations | |
| HK1207965A1 (en) | Pharmaceutical formulations containing methylnaltrexone | |
| IL162642A0 (en) | Formulations | |
| IL172824A0 (en) | Pharmaceutical formulations | |
| GB0302671D0 (en) | Pharmaceutical formulations | |
| IL171942A0 (en) | Compositions containing ecteinascidin-743 | |
| GB0303396D0 (en) | Medicinal compounds | |
| GB0319874D0 (en) | Novel formulation | |
| EP1694278A4 (en) | GLP-1 PHARMACEUTICAL COMPOSITIONS | |
| ZA200508984B (en) | Antifoaming formulations | |
| GB0323701D0 (en) | Formulations | |
| EP1503804A4 (en) | RADIOPHARMACEUTICAL FORMULATIONS | |
| GB0302672D0 (en) | Pharmaceutical formulations | |
| GB0325383D0 (en) | Oral formulations | |
| GB0316341D0 (en) | Pharmaceutical formulations | |
| GB0307765D0 (en) | Tissue-adhesive formulations | |
| AU2003264443A8 (en) | Preparation for external use | |
| IL174589A0 (en) | Pharmaceutical compositions containing tetrahydrobiopterin | |
| GB0214147D0 (en) | Formulations | |
| GB0316335D0 (en) | Pharmaceutical formulations | |
| SI1492513T1 (sl) | HFA-suspenzijske formulacije, ki vsebujejo antiholinergik | |
| GB0318503D0 (en) | Formulations | |
| GB0319551D0 (en) | Formulations | |
| GB0319549D0 (en) | Formulations | |
| GB0318871D0 (en) | Tissue-adhesive formulations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |